Nasus Pharma is trading at $3.58, up 16.99% in live trading on October 22, 2026, with healthcare-sector strength a possible support.
- No new company-specific announcement explaining the move was identified; the latest located company news was the September 29 NS003 trial update.
- XLV was up 1.35%, while the broader market was down; no direct catalyst for the sharp rise is established.
- Volume data was not provided.